Compare ADXN & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADXN | DTSS |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | Switzerland | China |
| Employees | 2 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 10.9M |
| IPO Year | N/A | N/A |
| Metric | ADXN | DTSS |
|---|---|---|
| Price | $8.23 | $1.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.1K | ★ 54.9K |
| Earning Date | 12-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $198,824.00 | ★ $64,349,277.00 |
| Revenue This Year | $86.57 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 68.56 |
| 52 Week Low | $6.51 | $1.03 |
| 52 Week High | $12.05 | $3.10 |
| Indicator | ADXN | DTSS |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 31.30 |
| Support Level | $7.59 | $1.18 |
| Resistance Level | $8.99 | $1.37 |
| Average True Range (ATR) | 0.52 | 0.17 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 50.97 | 22.67 |
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).